| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/12/2008 | CN101142215A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 03/12/2008 | CN101139348A Method for synthesizing 2-amido-6-chloropurine |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342006 Substituted 8-heteroaryl xanthines |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
| 03/06/2008 | US20080057005 Hydrogels for the controlled release of bioactive materials |
| 03/05/2008 | EP1893614A1 Inhibitor compounds |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/04/2008 | US7338945 (1R,4S) or (1S,4R)-1-Amino-4-(hydroxymethyl)-2-cyclopentene D- or L-hydrogen tartrate intermediates |
| 02/28/2008 | WO2008024981A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 02/28/2008 | WO2008024277A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/28/2008 | WO2008000744A3 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 02/28/2008 | WO2008000692A3 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | US20080051413 Nitrophenylpiperazine derivative of xanthine which relaxes tracheal airway and increases respiratory performance |
| 02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 02/28/2008 | CA2661044A1 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/28/2008 | CA2660957A1 2-phenoxy pyrimidinone analogues |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/27/2008 | EP1891071A2 Cyclopropanecarboxylate esters of acyclovir |
| 02/27/2008 | EP1891070A1 Prodrugs of a2b adenosine receptor antagonists |
| 02/27/2008 | EP1891069A1 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 02/27/2008 | EP1891042A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their therapeutic use on the central nervous system |
| 02/27/2008 | CN101130552A Process for preparing the antiviral agent [1s-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 02/27/2008 | CN101130543A Process for preparing the antiviral agent [1s-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 02/27/2008 | CN101130542A Synthesis method of antiviral nucleoside analogue |
| 02/27/2008 | CN101130540A Nucleoside derivative containing selenium and its preparation method |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/21/2008 | US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/20/2008 | EP1889846A1 Purine derivatives as A2a agonists |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1888587A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c |
| 02/20/2008 | EP1888586A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | CN101128473A Adenosine derivatives having a2a receptor activity |
| 02/20/2008 | CN101125854A Method for preparing adenine by hydrolyzing adenosine in high temperature liquid water without catalyst |
| 02/20/2008 | CN100369913C Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 02/19/2008 | US7332553 Functional monomers for molecular recognition and catalysis |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/14/2008 | WO2008019124A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/14/2008 | WO2008017161A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039477 Pyrazolopyrimidines as Cell Cycle Kinase Inhibitors |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | CA2660114A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/14/2008 | CA2659894A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/13/2008 | EP1885719A1 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors |
| 02/13/2008 | EP1689748B1 Novel 8-(piperazine-1-yl)- and 8-( 1,4 diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/06/2008 | EP1883639A1 Preparation of famciclovir and other purine derivatives |
| 02/06/2008 | EP1883637A2 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 02/06/2008 | CN101119996A Chemical compouns |
| 01/31/2008 | US20080027222 Chemiluminescent reagents |
| 01/31/2008 | US20080027081 Therapeutic compounds |
| 01/30/2008 | EP1881988A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| 01/30/2008 | EP1881984A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 01/30/2008 | EP1599477B1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 01/29/2008 | CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007128086A3 Novel viral replication inhibitor |
| 01/24/2008 | US20080021047 C-Purine Nucleoside Analogs As Inhibitors Of Rna-Dependent Rna Viral Polymerase |
| 01/24/2008 | CA2658404A1 Selective antagonists of a2a adenosine receptors |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | EP1105730B1 Enzyme inhibition immunoassay |
| 01/23/2008 | CN100363005C Composite preparation for treatment of dementia |
| 01/22/2008 | US7321035 Process for producing 2,6-dihalogenopurine |
| 01/17/2008 | WO2008008539A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 01/17/2008 | WO2008007392A2 Process for the preparation of tenofovir |
| 01/17/2008 | WO2008006563A1 Purine derivatives as a2a agonists |
| 01/17/2008 | WO2008006369A1 Adenosine receptor antagonists |
| 01/17/2008 | WO2007136817A3 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 01/17/2008 | US20080015352 zinc complexed with triiodothyronine; improved potency, stability, absorbability, targeted delivery |
| 01/17/2008 | US20080014660 High Quantum Yield Acridinium Compounds and Their Uses in Improving Assay Sensitivity |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | CA2657327A1 Fused heterocyclic derivatives and methods of use |
| 01/17/2008 | CA2656012A1 Purine derivatives as a2a agonists |
| 01/16/2008 | EP1877411A2 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
| 01/16/2008 | EP1285085B1 Method of determining thiopurine methyltransferase activity |
| 01/16/2008 | CN101107249A Purine derivatives acting as a2a receptor agonists |
| 01/16/2008 | CN101106977A Direct compression formulation and process |
| 01/16/2008 | CN100361992C Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors |
| 01/15/2008 | US7319101 catechol-O-methyltransferase (COMT) inhibitors such as N-{3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-allyl}-2,3-dihydroxy-benzamide used for the treatment of schizophrenia, Parkinson's disease and as antidepressants or cognition activators |
| 01/15/2008 | US7319041 Applications of acridinium compounds and derivatives in homogeneous assays |
| 01/10/2008 | WO2008005542A2 Antiviral phosphinate compounds |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2007121920A3 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/09/2008 | EP1874770A1 Phenylacetamides suitable as protein kinase inhibitors |
| 01/09/2008 | CN101103030A Medicaments with HM74A receptor activity |
| 01/09/2008 | CN100360529C Sesquiterpene subergorgia suberosa ketone and its preparing process and application |